Non-Hodgkin lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
Blanked the page |
Preeti Singh (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma. | |||
==Screening== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Disease]] | |||
[[Category:Hematology]] | |||
[[Category:Types of cancer]] | |||
[[Category:Mature chapter]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Revision as of 16:25, 28 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma.